DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Trade Payables History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Trade Payables | ₹1,211 Cr | ₹910 Cr | ₹824 Cr | ₹762 Cr | ₹796 Cr |
What is the latest Trade Payables ratio of DIVIS LABORATORIES ?
| Year | Trade Payables |
|---|---|
| Mar2026 | ₹1,211 Cr |
| Mar2025 | ₹910 Cr |
| Mar2024 | ₹824 Cr |
| Mar2023 | ₹762 Cr |
| Mar2022 | ₹796 Cr |
How is Trade Payables of DIVIS LABORATORIES Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,211 Cr | 33.08 | |
| Mar2025 | ₹910 Cr | 10.44 | |
| Mar2024 | ₹824 Cr | 8.14 | |
| Mar2023 | ₹762 Cr | -4.24 | |
| Mar2022 | ₹796 Cr | - | |
Compare Trade Payables of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹197,012.9 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| MANKIND PHARMA | ₹108,129.0 Cr | 2.9% | 5.4% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.5% |
13.1% |
10.9% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses